Buggy D, Higgins P, Moran C, O'Donovan F, McCarroll M
Department of Anaesthesia, Cappagh Orthopaedic Hospital, Dublin, Ireland.
Can J Anaesth. 1997 Mar;44(3):263-7. doi: 10.1007/BF03015363.
Postanaesthetic shivering occurs in 5-65% of patients. In addition to causing discomfort, it is associated with deleterious consequences. Our objective was to investigate the effect of 150 micrograms clonidine, at induction of anaesthesia, on perioperative core and peripheral temperature, incidence of postanaesthetic shivering and patients' perception of cold.
Sixty ASA 1 or 2 patients scheduled for elective orthopaedic limb surgery were randomly allocated to group 1, who received 150 micrograms clonidine iv, or group 2, who received a saline bolus iv, before induction. In all patients, anaesthesia was induced with fentanyl and propofol and maintained by spontaneous respiration (via a laryngeal mask airway) of oxygen, nitrous oxide and enflurane. Core (nasopharyngeal) and peripheral (dorsal hand) temperatures were recorded at induction and 15-min intervals. Nurses, unaware of the treatment groups, recorded visible shivering in the recovery room. When cognitive function returned, patients were asked to grade their perception of cold on a 10 cm linear analogue scale, higher scores indicating heat discomfort.
While core temperature decreased and peripheral temperature increased in both groups, there was no difference between the groups at any time. However, there was a lower incidence of shivering in the clonidine group (20% vs 66.7%, P < 0.001). Patients receiving clonidine felt warmer; thermal comfort score (median interquartile range) 5.9 (5.0-7.2) vs 5.0 (4.5-6.0), P < 0.05).
Clonidine 150 g iv at induction of anaesthesia reduces the incidence of shivering and patients' subjective perception of cold on emergence from general anaesthesia.
麻醉后寒战发生在5%至65%的患者中。除了引起不适外,还会带来有害后果。我们的目的是研究麻醉诱导时150微克可乐定对围手术期核心体温和外周体温、麻醉后寒战发生率以及患者冷感的影响。
60例计划行择期骨科肢体手术的ASA 1或2级患者,随机分为1组(麻醉诱导前静脉注射150微克可乐定)和2组(麻醉诱导前静脉注射生理盐水推注)。所有患者均用芬太尼和丙泊酚诱导麻醉,并通过喉罩气道自主呼吸氧气、氧化亚氮和安氟醚维持麻醉。在诱导时及每隔15分钟记录核心(鼻咽)温度和外周(手背)温度。护士在不知道治疗组的情况下记录恢复室中可见的寒战情况。当认知功能恢复时,要求患者在10厘米线性模拟量表上对冷感进行评分,分数越高表明热不适越严重。
两组患者的核心体温均下降,外周体温均升高,但两组在任何时候均无差异。然而,可乐定组的寒战发生率较低(20%对66.7%,P<0.001)。接受可乐定的患者感觉更温暖;热舒适度评分(中位数四分位间距)分别为5.9(5.0 -
麻醉诱导时静脉注射1克可乐定可降低全身麻醉苏醒时的寒战发生率患者的主观冷感。 7.2)对5.0(4.5 - 6.0),P<0.05)。
麻醉诱导时静脉注射15微克可乐固定可降低全身麻醉苏醒时的寒战发生率及患者的主观冷感。